About

The overall goal is to deliver evidence-based insights across the healthcare system to redefine obesity and optimize future treatment.

The SOPHIA project

The SOPHIA project (Stratification of Obesity Phenotypes to Optimise Future Obesity Therapy) is a Public-Private Partnership funded by the Innovative Medicines Initiative (IMI), in collaboration with the European Commission, and is part of a momentum shift in the study of obesity.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875534. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1D Exchange, JDRF, and Obesity Action Coalition. The project brings together healthcare professionals, academia, industry leaders, and patient organisations to change the future of obesity care.

Goals

The overall goal of SOPHIA is to deliver evidence-based insights across the healthcare system to redefine obesity and optimize future treatment. Our vision for obesity care is to better understand an individual’s risk and the overall health impact so we can personalize and prioritize care.

  1. Changing attitudes and perspectives surrounding obesity to build a common understanding
  2. Creation of a federated database
  3. Using obesity phenotypes to identify obesity risks and responses to treatment
  4. Using results to map opportunities for improved healthcare delivery and policy – transforming research into action

This takes us one step closer to identifying the right treatment for the right patient at the right time. Using machine learning, federated health data, and a unique approach to shared value, the project is part of a momentum shift and new approach to obesity care and management worldwide.